日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/01 | 5,761 | 5,819 | 5,734 | 5,819 | +65 | +1.1% | 397,300 |
| 2023/07/31 | 5,776 | 5,788 | 5,722 | 5,754 | +20 | +0.3% | 305,400 |
| 2023/07/28 | 5,650 | 5,752 | 5,603 | 5,734 | +54 | +1% | 412,800 |
| 2023/07/27 | 5,693 | 5,703 | 5,607 | 5,680 | -50 | -0.9% | 403,500 |
| 2023/07/26 | 5,696 | 5,745 | 5,686 | 5,730 | +50 | +0.9% | 377,800 |
| 2023/07/25 | 5,721 | 5,730 | 5,654 | 5,680 | -69 | -1.2% | 498,600 |
| 2023/07/24 | 5,676 | 5,749 | 5,639 | 5,749 | +144 | +2.6% | 490,500 |
| 2023/07/21 | 5,589 | 5,610 | 5,545 | 5,605 | +115 | +2.1% | 385,000 |
| 2023/07/20 | 5,536 | 5,546 | 5,484 | 5,490 | -36 | -0.7% | 338,300 |
| 2023/07/19 | 5,501 | 5,526 | 5,464 | 5,526 | +47 | +0.9% | 514,400 |
| 2023/07/18 | 5,460 | 5,550 | 5,427 | 5,479 | +36 | +0.7% | 394,700 |
| 2023/07/14 | 5,406 | 5,463 | 5,392 | 5,443 | +1 | ±0% | 338,500 |
| 2023/07/13 | 5,390 | 5,450 | 5,351 | 5,442 | +50 | +0.9% | 342,400 |
| 2023/07/12 | 5,389 | 5,413 | 5,340 | 5,392 | +6 | +0.1% | 366,500 |
| 2023/07/11 | 5,450 | 5,470 | 5,371 | 5,386 | -60 | -1.1% | 476,900 |
| 2023/07/10 | 5,428 | 5,470 | 5,366 | 5,446 | +22 | +0.4% | 523,100 |
| 2023/07/07 | 5,500 | 5,524 | 5,410 | 5,424 | -118 | -2.1% | 524,100 |
| 2023/07/06 | 5,706 | 5,714 | 5,500 | 5,542 | -169 | -3% | 545,500 |
| 2023/07/05 | 5,668 | 5,735 | 5,668 | 5,711 | +28 | +0.5% | 321,700 |
| 2023/07/04 | 5,724 | 5,751 | 5,656 | 5,683 | -121 | -2.1% | 587,300 |
| 2023/07/03 | 5,910 | 5,945 | 5,804 | 5,804 | -70 | -1.2% | 473,700 |
| 2023/06/30 | 5,980 | 5,980 | 5,872 | 5,874 | -178 | -2.9% | 509,000 |
| 2023/06/29 | 6,079 | 6,119 | 5,994 | 6,052 | -2 | ±0% | 434,200 |
| 2023/06/28 | 6,024 | 6,069 | 5,980 | 6,054 | +25 | +0.4% | 433,100 |
| 2023/06/27 | 6,149 | 6,149 | 5,977 | 6,029 | -179 | -2.9% | 541,700 |
| 2023/06/26 | 6,200 | 6,218 | 6,070 | 6,208 | ±0 | ±0% | 375,000 |
| 2023/06/23 | 6,369 | 6,380 | 6,200 | 6,208 | -109 | -1.7% | 376,800 |
| 2023/06/22 | 6,375 | 6,427 | 6,310 | 6,317 | -107 | -1.7% | 307,200 |
| 2023/06/21 | 6,479 | 6,548 | 6,420 | 6,424 | -3 | ±0% | 358,100 |
| 2023/06/20 | 6,452 | 6,470 | 6,394 | 6,427 | -57 | -0.9% | 211,500 |
| 2023/06/19 | 6,539 | 6,592 | 6,453 | 6,484 | +17 | +0.3% | 275,700 |
| 2023/06/16 | 6,373 | 6,514 | 6,361 | 6,467 | +89 | +1.4% | 504,000 |
| 2023/06/15 | 6,455 | 6,505 | 6,378 | 6,378 | -125 | -1.9% | 287,200 |
| 2023/06/14 | 6,547 | 6,586 | 6,450 | 6,503 | -37 | -0.6% | 344,400 |
| 2023/06/13 | 6,597 | 6,683 | 6,516 | 6,540 | -21 | -0.3% | 436,200 |
| 2023/06/12 | 6,516 | 6,672 | 6,513 | 6,561 | +77 | +1.2% | 256,000 |
| 2023/06/09 | 6,516 | 6,546 | 6,453 | 6,484 | +68 | +1.1% | 257,600 |
| 2023/06/08 | 6,561 | 6,574 | 6,387 | 6,416 | -124 | -1.9% | 228,500 |
| 2023/06/07 | 6,676 | 6,694 | 6,513 | 6,540 | -69 | -1% | 275,500 |
| 2023/06/06 | 6,515 | 6,625 | 6,482 | 6,609 | +53 | +0.8% | 224,400 |
| 2023/06/05 | 6,615 | 6,624 | 6,501 | 6,556 | +6 | +0.1% | 371,500 |
| 2023/06/02 | 6,500 | 6,600 | 6,450 | 6,550 | +140 | +2.2% | 281,100 |
| 2023/06/01 | 6,450 | 6,470 | 6,380 | 6,410 | +30 | +0.5% | 214,200 |
| 2023/05/31 | 6,290 | 6,440 | 6,280 | 6,380 | ±0 | ±0% | 584,400 |
| 2023/05/30 | 6,420 | 6,510 | 6,320 | 6,380 | -40 | -0.6% | 178,600 |
| 2023/05/29 | 6,500 | 6,510 | 6,390 | 6,420 | -20 | -0.3% | 207,600 |
| 2023/05/26 | 6,470 | 6,500 | 6,410 | 6,440 | -100 | -1.5% | 239,700 |
| 2023/05/25 | 6,600 | 6,710 | 6,540 | 6,540 | +90 | +1.4% | 387,800 |
| 2023/05/24 | 6,530 | 6,540 | 6,450 | 6,450 | -60 | -0.9% | 236,700 |
| 2023/05/23 | 6,550 | 6,580 | 6,480 | 6,510 | +80 | +1.2% | 231,700 |
451～
500
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 350,400円 | +8.0% | -15.3% | 3.54% | 9.84倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 333,800円 | +3.8% | -19.9% | 4.07% | 10.92倍 | 0.84倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 352,000円 | - | - | 0.00% | - | 163.04倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 169,500円 | +5.0% | +1.5% | 0.00% | 14.50倍 | 3.86倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ジーエヌアイ | 420,000円 | +21.7% | +999.9% | 0.00% | 17.59倍 | 5.82倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
